Hovione’s Board of Directors and shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione’s chief executive officer, effective April 1, 2022.
 
Guy Villax, who has been Hovione’s CEO for the past 25 years will now serve as a Member of the Board and shareholder. During his tenure, Hovione grew tenfold.
 
“It has been a privilege and honor to lead Hovione over the last decades. Hovione is a great company because of its people and its clients. It has been an amazing entrepreneurial and human journey with so many projects and unforgettable success stories. I have seen this company, founded by my parents, growing, evolving and constantly re-inventing itself,” said Villax. “Dr. Herbeaux joined Hovione nearly two years ago as COO and from day 1 brought change and contributed to financial and business successes.  We have worked together both on the strategy which will take Hovione to the next level and on making this transition smooth. I am certain that both the company and our Team-Members will continue to thrive under his leadership.”  
 
“I am honored to be entrusted with the role of Hovione’s CEO and I am deeply motivated to lead this team of talented professionals. Building on Guy Villax´s legacy of innovation and customer intimacy, we will continue to work to drive long-term growth for both ourselves and our customers maintaining the Hovione values. Hovione puts customers and patients at the center of everything it does and this focus will not change. Our customers can expect us to continue to deliver on what we promise and to offer innovative approaches to their project needs,” said Herbeaux.
 
Before joining Hovione in May 2020, Herbeaux held multiple high-level leadership positions at Evonik, where he last headed the Health Care Business Line. Herbeaux holds both a Master of Science and a Ph.D. in Mechanical Engineering with a research focus on Rheology from the University of Houston.